| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/11/2001 | EP1114051A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114048A1 Carboline derivatives as cgmp phosphodiesterase inhibitors |
| 07/11/2001 | EP1114046A1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 07/11/2001 | EP1114039A1 INHIBITORS OF p38 |
| 07/11/2001 | EP1114037A1 Benzoxazine and benzothiazine derivatives and their use in medicines |
| 07/11/2001 | EP1114035A1 Quinazoline derivatives and pharmaceutical applications thereof |
| 07/11/2001 | EP1114029A1 Novel compounds |
| 07/11/2001 | EP1113821A1 In situ injection of antigen-presenting cells with genetically enhanced cytokine expression |
| 07/11/2001 | EP1113820A1 Expandible microparticle intracellular delivery system |
| 07/11/2001 | EP1113818A1 METHODS OF TREATING IgE-ASSOCIATED DISORDERS AND COMPOSITIONS FOR USE THEREIN |
| 07/11/2001 | EP1113813A1 Method of using zot or zonulin to inhibit lymphocyte proliferation in an antigen-specific manner |
| 07/11/2001 | EP1113811A1 Chemokine receptor antagonist and cyclosporin in combined therapy |
| 07/11/2001 | EP1113800A1 Combinations of tetracyclic cyclic gmp-specific phosphodiesterase inhibitors with further therapeutic agents |
| 07/11/2001 | EP0969865A4 Mhc class ii antigen-presenting systems and methods for activating cd4?+ t cells |
| 07/11/2001 | EP0683783B1 Rapamycin derivative process for its preparation and its use |
| 07/11/2001 | CN1303435A TAO protein kinases and methods of use therefor |
| 07/11/2001 | CN1303394A Peptide compound for preventing and treating HIV infection and immunity diseases |
| 07/11/2001 | CN1303368A 1 Alpha-hydroxy-25-ene-vitamin D, analogs and use thereof |
| 07/11/2001 | CN1303367A Nitric oxide synthase inhibitors |
| 07/11/2001 | CN1303364A Aminocyclohexyl ether compounds and uses thereof |
| 07/11/2001 | CN1303301A Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease |
| 07/11/2001 | CN1303300A Isolated peptides corresponding to amino acid sequences of NY-ESO-1, wherein bind to MHC class I and MHC class II molecules, and uses thereof |
| 07/11/2001 | CN1303295A Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga |
| 07/11/2001 | CN1303289A Adenosine A3 receptor modulators |
| 07/11/2001 | CN1303285A Microemulsion preconcentrates containing piperidine substance P antagonist |
| 07/11/2001 | CN1303284A 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6] cyclohepta [1,2-b] pyridine oral compositions |
| 07/11/2001 | CN1302662A Oral immune using plant product containing non entero pathogene antigen |
| 07/11/2001 | CN1302652A Oral immune using plant product containing non entero pathogene antigen |
| 07/11/2001 | CN1302651A Oral immune using plant product containing hepatitis surface antigen |
| 07/11/2001 | CN1302630A Instant notoginseng particles |
| 07/11/2001 | CN1302605A Controlled releasing oral medicine composition |
| 07/11/2001 | CN1068214C Luxian oral liquid and its preparation method |
| 07/11/2001 | CA2331012A1 Method for the production of conjugates and uses thereof for the prevention and treatment of allergic reactions and autoimmune diseases |
| 07/10/2001 | US6258948 An n-acylamino compound; antiinflammatory agents, autoimmune diseases |
| 07/10/2001 | US6258945 HIV-1P-17 peptide fragments, compositions containing and methods for producing and using same |
| 07/10/2001 | US6258937 Hepadnavirus receptor |
| 07/10/2001 | US6258936 SpoIIIE |
| 07/10/2001 | US6258838 Compounds |
| 07/10/2001 | US6258833 Enzyme inhibitors and antiinflammatory agents |
| 07/10/2001 | US6258820 Synthesis and anti-tumor activity of 6,7-dialkoxy-4-phenylamino-quinazolines |
| 07/10/2001 | US6258815 Specific immunophilin ligands as antiasthmatics and immunosuppressants |
| 07/10/2001 | US6258811 Methods for preventing, inhibiting or treating graft rejection reactions in graft-versus-host disease (GVHD) and organ transplantation |
| 07/10/2001 | US6258802 Corticoid therapy |
| 07/10/2001 | US6258800 Prodrugs of benzofuranylethyl carbamate NK1 antagonists |
| 07/10/2001 | US6258790 Antisense modulation of integrin α4 expression |
| 07/10/2001 | US6258782 Hybrid polypeptides with enhanced pharmacokinetic properties |
| 07/10/2001 | US6258600 Antisense modulation of caspase 8 expression |
| 07/10/2001 | US6258564 Antibodies, production method of the antibodies, hybridomas which produce the antibodies, production method the hybirdomas and antigen proteins recognized by the antibodies |
| 07/10/2001 | US6258562 Human antibodies that bind human TNFα |
| 07/10/2001 | US6258341 Drug dispersion for oral inhalation and pulmonary absorption |
| 07/10/2001 | CA2175643C Utilization of retinoids in a cosmetic composition or in the preparation of a pharmaceutical composition |
| 07/10/2001 | CA2060666C Antigenic epitopes present on membrane-bound but not secreted iga |
| 07/10/2001 | CA2017135C Substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and -cyanamides, processes for their preparation and their use in medicaments |
| 07/05/2001 | WO2001048238A2 Chemotherapeutant screening method |
| 07/05/2001 | WO2001048231A2 Method of achieving persistent transgene expression |
| 07/05/2001 | WO2001048187A2 A molecular switch for regulating mammalian gene expression |
| 07/05/2001 | WO2001048171A1 IDENTIFICATION OF NOVEL SPLICE VARIANTS OF THE HUMAN CATALYTIC SUBUNIT Cβ OF cAMP-DEPENDENT PROTEIN KINASE AND THE USE THEREOF |
| 07/05/2001 | WO2001048154A1 Maturation-promoting agent for immature dendritic cells |
| 07/05/2001 | WO2001048117A1 Dry compositions containing hydrophobic amino acid |
| 07/05/2001 | WO2001048020A1 Composition for inhibiting macrophage activity |
| 07/05/2001 | WO2001048012A1 A new polypeptide- nadh dehydrogenase subunit i-11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048011A1 A new polypeptide- small hydrophilic plant seed protein 10 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048007A1 A new polypeptide-clathrin 12 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048004A1 A new polypeptide-heparin bind protein 10 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048003A1 A new polypeptide-amyloid gylcoprotein 10 and the polynucleotide encoding it |
| 07/05/2001 | WO2001048002A1 A new polypeptide - cytochrome b12 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047999A1 A new polypeptide-human gonadoliberin 11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047997A1 A new polypeptide-stathmin protein 8 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047986A1 A new polypeptide-thiolase protein 11 and the polynucleotide encoding it |
| 07/05/2001 | WO2001047963A2 Inhibitors of complement activation, their preparation and use |
| 07/05/2001 | WO2001047953A2 Antibodies against plasma cells |
| 07/05/2001 | WO2001047950A2 Basolateral sorting signal based on scf peptide and inhibitors thereof |
| 07/05/2001 | WO2001047922A2 Azaindoles |
| 07/05/2001 | WO2001047921A1 Pyrimidine and triazine kinase inhibitors |
| 07/05/2001 | WO2001047920A1 Benzazole derivatives and their use as jnk modulators |
| 07/05/2001 | WO2001047915A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047914A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047905A1 Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047897A1 Cytokine, especially tnf-alpha, inhibitors |
| 07/05/2001 | WO2001047895A1 Novel compounds having five-membered hetero-aromatic rings |
| 07/05/2001 | WO2001047892A1 Tricyclic protein kinase inhibitors |
| 07/05/2001 | WO2001047889A1 Tricyclic compounds |
| 07/05/2001 | WO2001047887A1 β-AMINO ACID COMPOUNDS AS INTEGRIN ANTAGONISTS |
| 07/05/2001 | WO2001047886A1 Nitrile derivatives as cathepsin k inhibitors |
| 07/05/2001 | WO2001047885A1 Substituted indole mannich bases |
| 07/05/2001 | WO2001047880A1 Cyclic amp-specific phosphodiesterase inhibitors |
| 07/05/2001 | WO2001047879A1 Pyrrolidines which inhibit camp-specific pde |
| 07/05/2001 | WO2001047878A1 Substituted pyrrole mannich bases to combat pain and allergic reactions |
| 07/05/2001 | WO2001047874A1 (hetero)bicyclymethanesulfonylamino-substituted hydroxamic acid derivatives |
| 07/05/2001 | WO2001047866A1 Substituted 1 and 2 naphthol mannich bases |
| 07/05/2001 | WO2001047859A1 Compounds active at the glucocorticoid receptor |
| 07/05/2001 | WO2001047553A1 Micelle-forming lipopeptides targeted at antigen presenting cells useful as vaccine adjuvants |
| 07/05/2001 | WO2001047549A2 Conjugate useful as building block for vaccine preparation |
| 07/05/2001 | WO2001047543A2 Activation and inhibition of the immune system |
| 07/05/2001 | WO2001047541A1 Optimized minigenes and peptides encoded thereby |
| 07/05/2001 | WO2001047537A1 Method for obtaining olive leaf extracts and applications thereof |
| 07/05/2001 | WO2001047533A2 INHIBITION OF GSK-3$g(b) |
| 07/05/2001 | WO2001047530A1 A method of therapy and prophylaxis of inflammation |
| 07/05/2001 | WO2001047526A1 Remedies for external use for allergic skin diseases |
| 07/05/2001 | WO2001047516A1 Immunosuppressants |